Hi, Continue visiting your profile
user

Login

Email

Password

Create account
Forget password
AnyGenes

EPIGENETIC REGULATION: A KEY MECHANISM IN GENE EXPRESSION CONTROL

Epigenetic regulation refers to processes that alter gene expression without changing the DNA sequence. These modifications control critical biological functions such as cellular differentiation, development, and responses to environmental signals, playing a major role in disease mechanisms.

Unlocking the mechanisms of epigenetic regulation with AnyGenes® qPCR arrays

AnyGenes® offers specialized qPCR arrays to analyze epigenetic regulation with precision. Our tools enable researchers to study gene expression changes driven by DNA methylation, histone modifications, and non-coding RNAs, providing insights into the molecular mechanisms behind cellular processes and disease progression.

AnyGenes Epigenetic Regulation qPCR Array for Analyzing DNA Methylation, Histone Modifications, and Gene Expression.

Discover our advanced qPCR arrays for Epigenetic Regulation research.

Epigenetic_regulation

Epigenetic control of adult stem cell function.

KEY MECHANISMS OF EPIGENETIC REGULATION

  • DNA Methylation: DNA methylation is the addition of a methyl group to the cytosine residues in CpG dinucleotides, which typically leads to gene repression.
  • Histone Modifications: Histones are proteins around which DNA is wrapped. Acetylation, methylation, and phosphorylation of histones alter chromatin structure, regulating gene accessibility.
  • Non-Coding RNAs: miRNAs and lncRNAs regulate gene expression at the RNA level, interacting with both RNA and chromatin.
  • Chromatin Remodeling: A critical process involving proteins that modify chromatin to control gene access and expression.

The interplay between these epigenetic mechanisms creates a complex regulatory network that governs gene expression in response to internal and external cues. Understanding these mechanisms not only sheds light on fundamental biological processes but also opens avenues for therapeutic interventions in diseases where epigenetic dysregulation plays a critical role.

KEY BIOMARKERS AND SIGNALING PATHWAYS

  1. DNA Methylation Markers:
    • DNA methyltransferases (DNMTs).
    • 5-methylcytosine (5mC).
  2. Histone Modifications:
    • Histone acetyltransferases (HATs).
    • Histone deacetylases (HDACs).
  3. Non-coding RNAs:
    • miRNAs regulate post-transcriptional gene expression by binding to mRNA and promoting degradation.

Signaling Pathways in Epigenetic 

Epigenetic changes are regulated by complex signaling pathways that control various cellular processes. Some of the key pathways involved include:

  1. TGF-β Signaling Pathway: Regulates epigenetic markers and cellular plasticity.
  2. PI3K/Akt Pathway: Affect histone acetylation and DNA methylation.
  3. Wnt/β-Catenin Pathway: Crucial for stem cell regulation and cancer progression.
  4. Notch Signaling Pathway: Impacts cell fate and interacts with epigenetic machinery in diseases like leukemia.

EPIGENETIC REGULATION IN DISEASES MECHANISMS

Epigenetic changes are closely linked to various diseases:

  • Cancer: Gene silencing through DNA methylation and histone modifications drives tumorigenesis.
  • Neurodegenerative Diseases: Epigenetic changes in genes involved in neuronal function contribute to conditions like Alzheimer's and Parkinson's.
  • Cardiovascular Diseases: Epigenetic changes influences inflammation, leading to atherosclerosis.
  • Aging: The accumulation of epigenetic changes over time influences aging and age-related diseases.

EPIGENETICS IN THERAPEUTICS

Epigenetic changes are reversible, making them promising therapeutic targets. Drugs like DNMT inhibitors and HDAC inhibitors are being studied as treatments for various diseases, including cancer. Epigenetic markers also play a crucial role in personalized medicine, providing insights into disease risks and drug responses.

AnyGenes® qPCR arrays empower researchers to explore the role of epigenetics in disease and therapeutics, aiding the development of precision treatments.

(1) Kinnaird A et al. Metabolic control of epigenetics in cancer. Nature (2016) 16: 694-707. 
(2) Chen QW et al. Epigenetic regulation and cancer (Review). Oncology reports (2014) 31: 523-532. 
(3) Cohen I et al. Histone Modifiers in Cancer: Friends or Foes? Genes & Cancer (2011) 2(6): 631-647. 
(4) Avgustinova A, Benitah SA. Epigenetic control of adult stem cell function. Nat Rev Mol Cell Biol. (2016) 17: 194-200. 
(5) Sharma S et al. Epigenetics in cancer. Carcinogenesis (2010) 31(1): 27-36. 
(6) Wu YS et al. Epigenetics in Metastatic Breast Cancer: Its Regulation and Implications in Diagnosis, Prognosis and Therapeutics. Curr Cancer Drug Targets. (2018).

EPIGENETIC REGULATION BIOMARKER LIST

Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file and send it at [email protected] to get started on your project.

You can check the biomarker list included in this pathway, see below: